Proteome Sciences secures further clinical contract

22nd Jun 2026 13:32

(Sharecast News) - Proteome Sciences said on Monday that it had secured a further significant clinical contract linked to its target engagement and chemoproteomics platform.

See latest RNS on InvestegateThe AIM-traded company said it expected the contract to act as a precursor to a new clinical trial programme due to start later in 2026.

Executive chairman Christopher Pearce said momentum and growth in Proteome's chemoproteomics services was continuing this year, adding that the company had generated "considerable interest and attention" at the recent American Society for Mass Spectrometry meeting in San Diego.

At 1016 BST, shares in Proteome Sciences were up 9.27% at 1.65p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

Top Risers

Share	Price	Change
Mothercare (MTC)	1.25	38.12%
Kazera Global (KZG)	1.15	21.05%
Petra Diamonds (PDL)	7.80	20%
Europa Oil & Gas (EOG)	1.60	18.52%
Futura Medical (FUM)	0.64	18.08%

Top Fallers

Share	Price	Change
eEnergy Group (EAAS)	3.30	-35.29%
Cellbxhealth (CLBX)	1.40	-20%
Marechale Cap. (MAC)	7.125	-16.18%
Lexington Gold (LEX)	2.75	-15.38%
Synthomer (SYNT)	97.80	-14.66%

Top By Volume

Share	Price	Volume
Forgent (FORG)	0.016	2,338,295,358
Quantum Helium (QHE)	0.03	784,898,120
Premier African Minerals (PREM)	0.02	491,790,562
Bezant Resources PLC (BZT)	0.135	295,943,963
Lloyds (LLOY)	109.20	223,111,298

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.